Guardion Health Sciences Price Prediction

GHSIDelisted Stock  USD 3.29  0.04  1.23%   
As of 26th of November 2024, the relative strength index (RSI) of Guardion Health's share price is approaching 36. This usually indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Guardion Health, making its price go up or down.

Oversold Vs Overbought

36

 
Oversold
 
Overbought
The successful prediction of Guardion Health's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Guardion Health Sciences, which may create opportunities for some arbitrage if properly timed.
Using Guardion Health hype-based prediction, you can estimate the value of Guardion Health Sciences from the perspective of Guardion Health response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Guardion Health to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Guardion because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Guardion Health after-hype prediction price

    
  USD 3.29  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardion Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.163.1312.87
Details
Naive
Forecast
LowNextHigh
0.084.1313.87
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
3.253.273.30
Details

Guardion Health After-Hype Price Prediction Density Analysis

As far as predicting the price of Guardion Health at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Guardion Health or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Guardion Health, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Guardion Health Estimiated After-Hype Price Volatility

In the context of predicting Guardion Health's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Guardion Health's historical news coverage. Guardion Health's after-hype downside and upside margins for the prediction period are 0.16 and 13.03, respectively. We have considered Guardion Health's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3.29
3.29
After-hype Price
13.03
Upside
Guardion Health is dangerous at this time. Analysis and calculation of next after-hype price of Guardion Health Sciences is based on 3 months time horizon.

Guardion Health Pink Sheet Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Guardion Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Guardion Health backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Guardion Health, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.20 
9.74
 0.00  
  0.02 
0 Events / Month
11 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
3.29
3.29
0.00 
0.00  
Notes

Guardion Health Hype Timeline

Guardion Health Sciences is currently traded for 3.29. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.02. Guardion is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.2%. %. The volatility of related hype on Guardion Health is about 11081.44%, with the expected price after the next announcement by competition of 3.31. About 21.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.32. Some equities with similar Price to Book (P/B) outperform the market in the long run. Guardion Health Sciences recorded a loss per share of 4.11. The entity last dividend was issued on the 24th of September 2024. The firm had 1:50 split on the 9th of January 2023. Given the investment horizon of 90 days the next projected press release will be in a few days.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

Guardion Health Related Hype Analysis

Having access to credible news sources related to Guardion Health's direct competition is more important than ever and may enhance your ability to predict Guardion Health's future price movements. Getting to know how Guardion Health's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Guardion Health may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BFRIBiofrontera 0.39 8 per month 0.00 (0.02) 14.63 (11.70) 46.72 
SHPHShuttle Pharmaceuticals 0.07 4 per month 0.00 (0.16) 10.08 (13.02) 50.96 
AKANAkanda Corp(0.06)2 per month 0.00 (0.20) 5.41 (7.22) 22.55 
CPHIChina Pharma Holdings 0.00 7 per month 4.89 (0.01) 9.09 (11.11) 43.71 
AGRXAgile Thrpe 0.00 0 per month 0.00 (0.29) 7.63 (7.16) 19.82 
TKNOAlpha Teknova(0.35)6 per month 5.04  0.1  12.84 (8.91) 32.06 
CYTHCyclo Therapeutics(0.04)5 per month 0.00 (0.05) 5.33 (5.19) 25.00 
PTPIPetros Pharmaceuticals 0.01 5 per month 0.00 (0.04) 7.41 (7.89) 45.54 
LFCRLifecore Biomedical 0.47 10 per month 6.50  0.06  9.76 (6.68) 30.90 
ORGOOrganogenesis Holdings 0.07 8 per month 3.29  0.1  7.55 (5.54) 37.89 
AQSTAquestive Therapeutics(0.24)7 per month 3.75  0.02  6.51 (7.14) 20.28 
EVOKEvoke Pharma(0.06)7 per month 4.66  0  6.20 (7.18) 48.38 
ADMPAdamis Pharma 0.05 4 per month 0.00 (0.28) 8.72 (11.60) 40.76 
ACRXAcelRx Pharmaceuticals 0.02 1 per month 4.26  0.07  13.85 (8.26) 29.52 
UPCUniverse Pharmaceuticals 0.26 7 per month 0.00 (0.30) 12.27 (16.26) 73.25 
QLIQilian International Holding 1.35 3 per month 6.62  0.16  19.23 (12.37) 61.58 
IMCCIm Cannabis Corp(0.27)2 per month 0.00 (0.04) 6.73 (7.77) 29.32 
RAPHRaphael Pharmaceutical 0.00 0 per month 0.00 (0.14) 0.00  0.00  84.24 
GSACGelStat Corp 0.00 0 per month 11.12  0.1  33.33 (25.00) 58.33 

Guardion Health Additional Predictive Modules

Most predictive techniques to examine Guardion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Guardion using various technical indicators. When you analyze Guardion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Guardion Health Predictive Indicators

The successful prediction of Guardion Health stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Guardion Health Sciences, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Guardion Health based on analysis of Guardion Health hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Guardion Health's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Guardion Health's related companies.

Story Coverage note for Guardion Health

The number of cover stories for Guardion Health depends on current market conditions and Guardion Health's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Guardion Health is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Guardion Health's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Guardion Health Short Properties

Guardion Health's future price predictability will typically decrease when Guardion Health's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Guardion Health Sciences often depends not only on the future outlook of the potential Guardion Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Guardion Health's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.3 M
Cash And Short Term Investments6.4 M
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Consideration for investing in Guardion Pink Sheet

If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account